Literature DB >> 10987259

Frequent cyclin D1 expression in chromate-induced lung cancers.

M Katabami1, H Dosaka-Akita, T Mishina, K Honma, K Kimura, Y Uchida, K Morikawa, H Mikami, S Fukuda, Y Inuyama, Y Ohsaki, Y Kawakami.   

Abstract

Ex-chromate workers are frequently afflicted with lung cancers, especially central-type squamous cell carcinomas (SCCs) of the lung. However, little is known about the molecular and cellular biologic characteristics of chromate-induced lung cancers. We investigated expression of cyclin D1, bcl-2, and p53 proteins in chromate-induced lung cancers by immunohistochemistry, compared with those in lung cancers from nonexposed individuals and those in individuals with pneumoconiosis. Of 19 chromate-induced lung cancers, 16 tumors were SCCs, including 11 central and 5 peripheral types. Eleven (69%) of 16 chromate SCCs showed cyclin D1 expression. In contrast, cyclin D1 expression was observed in only 3 (12%) of 26 SCCs from nonexposed individuals and 6 (16%) of 37 SCCs that developed in patients with pneumoconiosis, respectively. The frequency of cyclin D1 expression proved to be significantly higher in chromate-induced SCCs than in SCCs from nonexposed individuals and from those with pneumoconiosis (P < .001). When comparisons were extended to all histologic types of lung cancer, cyclin D1 expression was observed significantly more often in chromate-induced lung cancers than in lung cancers from nonexposed subjects and those from patients with pneumoconiosis (11 [58%] of 19 v 5 [10%] of 52, P < .001, and 7 [11%] of 63, P < .001, respectively). Frequencies of bcl-2 and p53 expression were not significantly different among lung cancers from ex-chromate workers, nonexposed individuals and those with pneumoconiosis. The current study suggests that cyclin D1 expression may be involved in the development of chromate-induced lung cancers, although its underlying mechanism remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987259     DOI: 10.1053/hupa.2000.9081

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.

Authors:  Mary Tsikitis; Zhikai Zhang; Winfried Edelman; David Zagzag; Ganjam V Kalpana
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-12       Impact factor: 11.205

2.  Comparison of gene expression profiles in chromate transformed BEAS-2B cells.

Authors:  Hong Sun; Harriet A Clancy; Thomas Kluz; Jiri Zavadil; Max Costa
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 3.  Cytogenomics of hexavalent chromium (Cr 6+) exposed cells: a comprehensive review.

Authors:  Akanksha Nigam; Shivam Priya; Preeti Bajpai; Sushil Kumar
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.